Evidence map›Paper›PMID 42477058›Full record

ArticleNature immunology2026

Endothelial cell-intrinsic NOD2 signaling regulates the intestinal immune response through the generation of effector and memory T cells.

Boyan K Tsankov, Madison Denney, Jennifer S Y Ahn, Charles Carr, Nayanan Nathan, Derek K L Tsang, Giuliano Bayer, Lauren Baerg, Alexander Luchak, Tapas Mukherjee and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Boyan K TsankovDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-6525-5173
Madison DenneyDepartment of Laboratory Medicine and Pathophysiology, University of Toronto, Toronto, Ontario, Canada.
Jennifer S Y AhnDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0009-0005-5305-8956
Charles CarrJill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Nayanan NathanDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-1408-5661
Derek K L TsangDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Giuliano BayerDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Lauren BaergInstitute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-4297-3666
Alexander LuchakDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Tapas MukherjeeDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-9433-3716
Elaine TamDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.
Bana SammanDepartment of Laboratory Medicine and Pathophysiology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0009-0006-9970-2708
Jennifer L GommermanDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0003-4576-6168
Stephen E GirardinDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-9208-8879
Dana J PhilpottDepartment of Immunology, University of Toronto, Toronto, Ontario, Canada. dana.philpott@utoronto.ca.ORCID http://orcid.org/0000-0003-3238-6254

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-18367Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) PJT-303157
6 · The paper itself

Abstract

Crohn's disease (CD) involves aberrant intestinal T cell immunity and genetic variants associated with disease development. Notably, mutations impairing NOD2 signaling represent the largest genetic risk factor for CD. Paradoxically, although NOD2 variants are associated with CD, its ligand, bacterial muramyl dipeptide, is a potent stimulator of immunity, long recognized as the minimal component required for the adjuvanticity of complete Freund's adjuvant. This paradox highlights a critical gap in our understanding of how NOD2 coordinates the innate-adaptive immune cross-talk required to maintain intestinal homeostasis. Here we show that NOD2 engagement by muramyl dipeptide drives T cell homing to the mesenteric lymph nodes during both homeostasis and infection. This recruitment promotes antigen-specific effector and memory T cell accumulation in the ileal lamina propria, a process essential for effective recall responses and clearance of secondary infection. Mechanistically, this process requires endothelial-intrinsic NOD2 expression, which drives a specialized transcriptional program for leukocyte recruitment.

Indexed as

Crohn DiseaseEndothelial CellsIntestinal MucosaIntestinesMemory T CellsNod2 Signaling Adaptor ProteinAcetylmuramyl-Alanyl-IsoglutamineAnimalsHumansImmunity, InnateImmunologic MemoryMiceMice, Inbred C57BLMice, KnockoutSignal TransductionAcetylmuramyl-Alanyl-IsoglutamineNod2 protein, mouseNod2 Signaling Adaptor Protein

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.